Kevin Herde

2021 - MARAVAI LIFESCIENCES HOLDINGS

In 2021, Kevin Herde earned a total compensation of $841.6K as Chief Financial Officer at MARAVAI LIFESCIENCES HOLDINGS.

Compensation breakdown

Non-Equity Incentive Plan$420,000
Salary$412,788
Other$8,810
Total$841,598

Herde received $420K in non-equity incentive plan, accounting for 50% of the total pay in 2021.

Herde also received $412.8K in salary and $8.8K in other compensation.

Rankings

In 2021, Kevin Herde's compensation ranked 9,332nd out of 12,415 executives tracked by ExecPay. In other words, Herde earned more than 24.8% of executives.

ClassificationRankingPercentile
All
9,332
out of 12,415
25th
Division
Manufacturing
4,137
out of 5,505
25th
Major group
Chemicals And Allied Products
1,823
out of 2,375
23rd
Industry group
Drugs
1,618
out of 2,096
23rd
Industry
Pharmaceutical Preparations
1,201
out of 1,546
22nd
Source: SEC filing on April 14, 2022.

Herde's colleagues

We found five more compensation records of executives who worked with Kevin Herde at MARAVAI LIFESCIENCES HOLDINGS in 2021.

2021

Lisa Sellers

MARAVAI LIFESCIENCES HOLDINGS

Chief Operating Officer

2021

Carl Hull

MARAVAI LIFESCIENCES HOLDINGS

Chief Executive Officer

2021

Christine Dolan

MARAVAI LIFESCIENCES HOLDINGS

Chief Operating Officer

2021

Brian Neel

MARAVAI LIFESCIENCES HOLDINGS

Chief Operating Officer

2021

Kurt Oreshack

MARAVAI LIFESCIENCES HOLDINGS

General Counsel

News

You may also like